Part of Long-Term Growth Strategy
IRVINE, CA -- (Marketwire) -- 08/19/08 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), the
world's leading dental laser company, today announced the global launch of
a new software upgrade that includes innovations designed to extend the
capabilities and useful life of installed first generation Waterlase(TM)
hard and soft tissue dental laser systems. This first-time offering for
BIOLASE laser dental products gives these earlier-generation lasers
variable pulse repetition rates (frequency) similar to the Company's latest
generation Waterlase MD(TM) and Waterlase® C100 systems, for smoother
tissue cutting and increased patient comfort. The Waterlase is used to
perform a variety of dental procedures, including cavity preparation,
caries removal, tooth etching and a wide range of soft tissue (gum)
procedures.
"Offering software upgrades is another part of our overall plan to achieve
the highest levels of customer satisfaction and expand our product
offerings," said Chief Executive Officer Jake St. Philip. "Extending the
useful life of our systems demonstrates our long-term commitment to
Waterlase Dentists around the globe, confirms our technological leadership
position, and strengthens our long-term opportunities to accelerate our
growth." The Company recently reported 13.4 percent growth over the prior
year period for the first half of 2008 and has an average 8-year growth
rate of over 30 percent. The software upgrade comes one month after the
introduction of the new Waterlase C100, which is due to begin shipping at
the end of the current quarter.
The software upgrade includes the Waterlase LB 3.0 Operating System which
provides five different repetition rates (from 10 to 30Hz) in addition to
the original 20 Hz and a new CPU board. The upgrade is being launched this
week with the Company's exclusive North American distribution partner Henry
Schein Dental, part of Melville, NY-based Henry Schein, Inc. (NASDAQ: HSIC), and installations will start in Waterlase Dentists' offices in
September. It is being launched internationally throughout the next few
weeks. For software upgrade information, contact BIOLASE Customer Service
domestically at 1-800-321-6717 or internationally at 1-949-361-1200.
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading
dental laser company, develops, manufactures and markets lasers and related
products that advance the practice of dentistry and medicine. The Company's
products incorporate patented and patent pending technologies designed to
provide clinically superior performance with less pain and faster recovery
times. BIOLASE's principal products are dental laser systems that perform a
broad range of dental procedures, including cosmetic and complex surgical
applications. Other products under development address ophthalmology and
other medical and consumer markets.
This press release may contain forward-looking statements within the
meaning of safe harbor provided by the Securities Reform Act of 1995 that
are based on the current expectations and estimates by our management.
These forward-looking statements can be identified through the use of words
such as "anticipates," "expects," "intends," "plans," "believes," "seeks,"
"estimates," "may," "will," and variations of these words or similar
expressions. Forward-looking statements are based on management's current,
preliminary expectations and are subject to risks, uncertainties and other
factors which may cause the Company's actual results to differ materially
from the statements contained herein, and are described in the Company's
reports it files with the Securities and Exchange Commission, including its
annual and quarterly reports. No undue reliance should be placed on
forward-looking statements. Such information is subject to change, and we
undertake no obligation to update such statements.
For further information, contact:
David M. Mulder
Chief Financial Officer of BIOLASE Technology, Inc.
+1-949-361-1200
or
Jill Bertotti
Allen & Caron
+1-949-474-4300